Press Releases about Lexaria Bioscience Corp![]()
Lexaria's DehydraTECHTM-CBD Reduces Arterial Stiffness, Results Confirmed in Human Clinical Study HYPER-H21-2
December 08, 2021
Via AccessWire
Topics
Intellectual Property
Exposures
Intellectual Property
![]() ![]()
Lexaria Announces Ambitious New Hypertension Study HYPER-H21-4
November 03, 2021
Via AccessWire
Topics
Intellectual Property
Exposures
Intellectual Property
![]()
Lexaria Announces R&D Program to Compare First and Only FDA-Approved Prescription Cannabidiol
November 01, 2021
Via AccessWire
Topics
Intellectual Property
Exposures
Intellectual Property
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|